Literature DB >> 10188905

Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation.

D Matsuzoe1, T Hideshima, K Ohshima, K Kawahara, T Shirakusa, A Kimura.   

Abstract

When multiple synchronous lung tumours are identified, discrimination of multicentric lung cancers from intrapulmonary metastases by clinical findings is often difficult. We used genetic alterations in p53 gene as a discrimination marker of double primary lung cancers from single lung cancer with intrapulmonary metastasis. Twenty of 861 patients with primary lung cancer who underwent lung resection were selected as subjects because they showed synchronous double solid tumours of the same histological type in the unilateral lung without distant metastases. In addition, they had been diagnosed as lung carcinoma with intrapulmonary metastasis by clinical and histological findings. DNAs were extracted from paraffin-embedded tissue of paired tumours from these 20 patients. Exons 5-9 of the p53 gene were examined for genetic alterations in the tumours by polymerase chain reaction, single-strand conformation polymorphism analysis and subsequent DNA sequencing analysis. Three different patterns in the distribution of p53 mutations in double lung tumours were observed: [A] mutation in only one of the tumours (four cases), [B] different mutations in the tumours (two cases), and [C] same mutation in both tumours (one case). The cases of [A] or [B] patterns could be classified as double primary lung cancers, while the case of the [C] pattern was suggested to be lung cancer with intrapulmonary metastasis. These results suggested that the multicentric cancers were more frequent than the intrapulmonary metastatic cancers in double cancer cases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10188905      PMCID: PMC2362717          DOI: 10.1038/sj.bjc.6690247

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  Prognosis and survival in resected lung carcinoma based on the new international staging system.

Authors:  T Naruke; T Goya; R Tsuchiya; K Suemasu
Journal:  J Thorac Cardiovasc Surg       Date:  1988-09       Impact factor: 5.209

2.  Intrapulmonary sublesions detected before surgery in patients with lung cancer.

Authors:  H Kunitoh; K Eguchi; K Yamada; R Tsuchiya; M Kaneko; N Moriyama; M Noguchi
Journal:  Cancer       Date:  1992-10-01       Impact factor: 6.860

3.  p53 gene mutations in primary lung tumors are conserved in brain metastases.

Authors:  U Schlegel; M R Rosenfeld; M Volkenandt; M Rosenblum; J Dalmau; H Furneaux
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

4.  Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma cell lines.

Authors:  J Caamano; B Ruggeri; S Momiki; A Sickler; S Y Zhang; A J Klein-Szanto
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

5.  Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.

Authors:  K Y Chung; T Mukhopadhyay; J Kim; A Casson; J Y Ro; H Goepfert; W K Hong; J A Roth
Journal:  Cancer Res       Date:  1993-04-01       Impact factor: 12.701

6.  Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung.

Authors:  Y Kishimoto; Y Murakami; M Shiraishi; K Hayashi; T Sekiya
Journal:  Cancer Res       Date:  1992-09-01       Impact factor: 12.701

7.  Unifocal origin of advanced human epithelial ovarian cancers.

Authors:  C H Mok; S W Tsao; R C Knapp; P M Fishbaugh; C C Lau
Journal:  Cancer Res       Date:  1992-09-15       Impact factor: 12.701

8.  Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma.

Authors:  T Oda; H Tsuda; A Scarpa; M Sakamoto; S Hirohashi
Journal:  Cancer Res       Date:  1992-07-01       Impact factor: 12.701

9.  p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.

Authors:  T Mitsudomi; S M Steinberg; M M Nau; D Carbone; D D'Amico; S Bodner; H K Oie; R I Linnoila; J L Mulshine; J D Minna
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

10.  Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

Authors:  I Chiba; T Takahashi; M M Nau; D D'Amico; D T Curiel; T Mitsudomi; D L Buchhagen; D Carbone; S Piantadosi; H Koga
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

View more
  17 in total

1.  Testing clonal relatedness of tumors using array comparative genomic hybridization: a statistical challenge.

Authors:  Irina Ostrovnaya; Colin B Begg
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

2.  Clinical features of multiple lung cancers based on thin-section computed tomography: what are the appropriate surgical strategies for second lung cancers?

Authors:  Aritoshi Hattori; Kenji Suzuki; Kazuya Takamochi; Shiaki Oh
Journal:  Surg Today       Date:  2014-05-22       Impact factor: 2.549

Review 3.  International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Authors:  William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim R Geisinger; Yasushi Yatabe; David G Beer; Charles A Powell; Gregory J Riely; Paul E Van Schil; Kavita Garg; John H M Austin; Hisao Asamura; Valerie W Rusch; Fred R Hirsch; Giorgio Scagliotti; Tetsuya Mitsudomi; Rudolf M Huber; Yuichi Ishikawa; James Jett; Montserrat Sanchez-Cespedes; Jean-Paul Sculier; Takashi Takahashi; Masahiro Tsuboi; Johan Vansteenkiste; Ignacio Wistuba; Pan-Chyr Yang; Denise Aberle; Christian Brambilla; Douglas Flieder; Wilbur Franklin; Adi Gazdar; Michael Gould; Philip Hasleton; Douglas Henderson; Bruce Johnson; David Johnson; Keith Kerr; Keiko Kuriyama; Jin Soo Lee; Vincent A Miller; Iver Petersen; Victor Roggli; Rafael Rosell; Nagahiro Saijo; Erik Thunnissen; Ming Tsao; David Yankelewitz
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

4.  Diagnosis of metachronous multiple lung adenocarcinoma at the cut-end by epidermal growth factor receptor mutation status discordance 4 years after sublobar resection for adenocarcinoma in situ: report of a case.

Authors:  Tetsuya Isaka; Tomoyuki Yokose; Hiroyuki Ito; Naoko Imamura; Masato Watanabe; Kentaro Imai; Teppei Nishii; Kouzo Yamada; Haruhiko Nakayama; Munetaka Masuda
Journal:  Surg Today       Date:  2014-11-08       Impact factor: 2.549

5.  Evaluation of the clonal origin of multiple primary melanomas using molecular profiling.

Authors:  Irene Orlow; Diana V Tommasi; Bradley Bloom; Irina Ostrovnaya; Javier Cotignola; Urvi Mujumdar; Klaus J Busam; Achim A Jungbluth; Richard A Scolyer; John F Thompson; Bruce K Armstrong; Marianne Berwick; Nancy E Thomas; Colin B Begg
Journal:  J Invest Dermatol       Date:  2009-03-12       Impact factor: 8.551

6.  [Research Progress in Distinguishing Methods of Simultaneous Multiple Primary Lung Cancer and Intrapulmonary Metastasis].

Authors:  Jifan Wang; Te Zhang; Hanlin Ding; Gaochao Dong; Lin Xu; Feng Jiang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-05-20

7.  "Different trend" in multiple primary lung cancer and intrapulmonary metastasis.

Authors:  Cheng Shen; Xin Wang; Long Tian; Yubin Zhou; Dali Chen; Heng Du; Weiya Wang; Lunxu Liu; Guowei Che
Journal:  Eur J Med Res       Date:  2015-02-20       Impact factor: 2.175

8.  A novel differential diagnostic model for multiple primary lung cancer: Differentially-expressed gene analysis of multiple primary lung cancer and intrapulmonary metastasis.

Authors:  Dali Chen; Longyong Mei; Yubin Zhou; Cheng Shen; Huan Xu; Zhongxi Niu; Guowei Che
Journal:  Oncol Lett       Date:  2015-01-15       Impact factor: 2.967

9.  The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report.

Authors:  Ryutaro Mori; Manabu Futamura; Kasumi Morimitsu; Chiemi Saigo; Tatsuhiko Miyazaki; Kazuhiro Yoshida
Journal:  World J Surg Oncol       Date:  2017-06-29       Impact factor: 2.754

Review 10.  Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature review.

Authors:  James Sherwood; Simon Dearden; Marianne Ratcliffe; Jill Walker
Journal:  J Exp Clin Cancer Res       Date:  2015-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.